276 related articles for article (PubMed ID: 18214475)
1. Anti-angiogenic active immunotherapy: a new approach to cancer treatment.
Pan J; Jin P; Yan J; Kabelitz D
Cancer Immunol Immunother; 2008 Aug; 57(8):1105-14. PubMed ID: 18214475
[TBL] [Abstract][Full Text] [Related]
2. Cancer immunotherapy of targeting angiogenesis.
Hou J; Tian L; Wei Y
Cell Mol Immunol; 2004 Jun; 1(3):161-6. PubMed ID: 16219162
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic naked DNA vaccination with the human vascular endothelial growth factor induces an anti-tumor response in C57Bl/6 mice.
Bequet-Romero M; Ayala M; Acevedo BE; Rodríguez EG; Ocejo OL; Torrens I; Gavilondo JV
Angiogenesis; 2007; 10(1):23-34. PubMed ID: 17273909
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a xenogeneic VEGF vaccine in dogs with soft tissue sarcoma.
Kamstock D; Elmslie R; Thamm D; Dow S
Cancer Immunol Immunother; 2007 Aug; 56(8):1299-309. PubMed ID: 17502972
[TBL] [Abstract][Full Text] [Related]
5. Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies.
Shojaei F; Ferrara N
Drug Resist Updat; 2008 Dec; 11(6):219-30. PubMed ID: 18948057
[TBL] [Abstract][Full Text] [Related]
6. Monitoring of circulating angiogenic factors in dendritic cell-based cancer immunotherapy.
Brostjan C; Bayer A; Zommer A; Gornikiewicz A; Roka S; Benkö T; Yaghubian R; Jakesz R; Steger G; Gnant M; Friedl J; Stift A
Cancer; 2003 Nov; 98(10):2291-301. PubMed ID: 14601101
[TBL] [Abstract][Full Text] [Related]
7. Pathways mediating VEGF-independent tumor angiogenesis.
Ferrara N
Cytokine Growth Factor Rev; 2010 Feb; 21(1):21-6. PubMed ID: 20005148
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor/fibroblast growth factor receptor system in angiogenesis.
Presta M; Dell'Era P; Mitola S; Moroni E; Ronca R; Rusnati M
Cytokine Growth Factor Rev; 2005 Apr; 16(2):159-78. PubMed ID: 15863032
[TBL] [Abstract][Full Text] [Related]
9. Brain angiogenesis in developmental and pathological processes: therapeutic aspects of vascular endothelial growth factor.
Shibuya M
FEBS J; 2009 Sep; 276(17):4636-43. PubMed ID: 19664071
[TBL] [Abstract][Full Text] [Related]
10. [Angiogenesis and metastasis of carcinoma].
Chen L; Shibasaki F
Clin Calcium; 2006 Apr; 16(4):613- 19. PubMed ID: 16582512
[TBL] [Abstract][Full Text] [Related]
11. Vaccines targeting tumor vasculature: a new approach for cancer immunotherapy.
Croix BS
Cytotherapy; 2007; 9(1):1-3. PubMed ID: 17354097
[No Abstract] [Full Text] [Related]
12. [Tumor angiogenesis].
Bikfalvi A
Bull Cancer; 2007; 94(7 Suppl):F193-8. PubMed ID: 17964996
[TBL] [Abstract][Full Text] [Related]
13. Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors.
Casanovas O; Hicklin DJ; Bergers G; Hanahan D
Cancer Cell; 2005 Oct; 8(4):299-309. PubMed ID: 16226705
[TBL] [Abstract][Full Text] [Related]
14. Effective inhibition of the epidermal growth factor/epidermal growth factor receptor binding by anti-epidermal growth factor antibodies is related to better survival in advanced non-small-cell lung cancer patients treated with the epidermal growth factor cancer vaccine.
García B; Neninger E; de la Torre A; Leonard I; Martínez R; Viada C; González G; Mazorra Z; Lage A; Crombet T
Clin Cancer Res; 2008 Feb; 14(3):840-6. PubMed ID: 18245547
[TBL] [Abstract][Full Text] [Related]
15. Keratinocyte growth factor induces vascular endothelial growth factor-A expression in colorectal cancer cells.
Narita K; Fujii T; Ishiwata T; Yamamoto T; Kawamoto Y; Kawahara K; Nakazawa N; Naito Z
Int J Oncol; 2009 Feb; 34(2):355-60. PubMed ID: 19148469
[TBL] [Abstract][Full Text] [Related]
16. Anti-angiogenic therapy against gastrointestinal tract cancers.
Iwasaki J; Nihira S
Jpn J Clin Oncol; 2009 Sep; 39(9):543-51. PubMed ID: 19531544
[TBL] [Abstract][Full Text] [Related]
17. Targeting angiogenesis in head and neck cancer.
Seiwert TY; Cohen EE
Semin Oncol; 2008 Jun; 35(3):274-85. PubMed ID: 18544442
[TBL] [Abstract][Full Text] [Related]
18. Chapter 6. Mouse models to investigate anti-cancer effects of VEGF inhibitors.
Crawford Y; Ferrara N
Methods Enzymol; 2008; 445():125-39. PubMed ID: 19022058
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumoral effect of active immunotherapy in C57BL/6 mice using a recombinant human VEGF protein as antigen and three chemically unrelated adjuvants.
Morera Y; Bequet-Romero M; Ayala M; Lamdán H; Agger EM; Andersen P; Gavilondo JV
Angiogenesis; 2008; 11(4):381-93. PubMed ID: 19034678
[TBL] [Abstract][Full Text] [Related]
20. Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degeneration.
Ciulla TA; Rosenfeld PJ
Curr Opin Ophthalmol; 2009 May; 20(3):166-74. PubMed ID: 19381089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
